Effects of Smoking Cessation on Plasma Levels of Leptin, Ghrelin, Glucagon-Like Peptide 1, and Nerve Growth Factor

금연이 혈중 Leptin, Ghrelin, Glucagon-Like Peptide 1, Nerve Growth Factor의 농도에 미치는 영향

  • Lee, Hee-Mi (Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Won, Wang-Youn (Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Dai-Jin (Department of Psychiatry, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • 이희미 (가톨릭대학교 의과대학 서울성모병원 정신과학교실) ;
  • 원왕연 (가톨릭대학교 의과대학 서울성모병원 정신과학교실) ;
  • 김대진 (가톨릭대학교 의과대학 서울성모병원 정신과학교실)
  • Received : 2010.11.15
  • Accepted : 2010.11.25
  • Published : 2011.05.31

Abstract

Objectives It is well-known that tobacco smoking is related to various disease entities including chronic obstructive pulmonary disease, inflammation, cardiovascular disease, and neoplasms. The prohibition of smoking is important for the protection of these health problems. Regarding leptin, ghrelin, glucagon-like peptide 1 (GLP-1), and nerve growth factor (NGF) levels, correlations with the smoking are suggested but the reports on the effects after smoking cessation are not sufficient. Method The changes of plasma levels of leptin, ghrelin, GLP-1, and NGF levels were analyzed after quitting smoking in Korean adults. Eleven participants succeeding in quitting smoking among 37 male smokers were included in the final analysis. The plasma levels of NGF, leptin, ghrelin, and GLP-1 were measured before and after 8-weeks period of smoking cessation. Results The plasma level of leptin increased after 4 weeks of smoking cessation. In addition, the plasma level of NGF increased after 8 weeks of smoking cessation (p < 0.05). Conclusion Our results suggested that smoking cessation induces increases in leptin and the NGF level after smoking cessation. Many toxic materials including nicotine in the cigarette may be related to these changes of plasma level of leptin and NGF, playing a key role in neurogenesis and synaptic plasticity.

Keywords

References

  1. Hatsukami DK, Stead LF, Gupta PC. Tobacco addiction. Lancet 2008;371:2027-2038. https://doi.org/10.1016/S0140-6736(08)60871-5
  2. Markou A. Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci 2008;363:3159-3168. https://doi.org/10.1098/rstb.2008.0095
  3. Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry 2001;49:258-267. https://doi.org/10.1016/S0006-3223(00)01094-5
  4. Flores CM, Davila-Garcia MI, Ulrich YM, Kellar KJ. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem 1997;69:2216-2219.
  5. Nguyen HN, Rasmussen BA, Perry DC. Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther 2003;307:1090-1097. https://doi.org/10.1124/jpet.103.056408
  6. Browne SE, Lin L, Mattsson A, Georgievska B, Isacson O. Selective antibody-induced cholinergic cell and synapse loss produce sustained hippocampal and cortical hypometabolism with correlated cognitive deficits. Exp Neurol 2001;170:36-47. https://doi.org/10.1006/exnr.2001.7700
  7. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS. Neurotrophic factors: from molecule to man. Trends Neurosci 1994;17:182-190. https://doi.org/10.1016/0166-2236(94)90099-X
  8. Barde YA. The nerve growth factor family. Prog Growth Factor Res 1990;2:237-248. https://doi.org/10.1016/0955-2235(90)90021-B
  9. Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev 1968;48:534-569. https://doi.org/10.1152/physrev.1968.48.3.534
  10. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-1162. https://doi.org/10.1126/science.3306916
  11. Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 1987;109:145-178.
  12. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-1127. https://doi.org/10.1111/j.1360-0443.1991.tb01879.x
  13. Drago J, Kilpatrick TJ, Koblar SA, Talman PS. Growth factors: potential therapeutic applications in neurology. J Neurol Neurosurg Psychiatry 1994;57:1445-1450. https://doi.org/10.1136/jnnp.57.12.1445
  14. Hefti F, Dravid A, Hartikka J. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 1984;293:305-311. https://doi.org/10.1016/0006-8993(84)91237-X
  15. Rylett RJ, Williams LR. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci 1994;17: 486-490. https://doi.org/10.1016/0166-2236(94)90138-4
  16. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 1998;27:1-39. https://doi.org/10.1016/S0165-0173(98)00004-6
  17. Angelucci F, Mathe AA, Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res 2004;146:151-165.
  18. Lang UE, Gallinat J, Kuhn S, Jockers-Scherubl C, Hellweg R. Nerve growth factor and smoking cessation. Am J Psychiatry 2002;159: 674-675. https://doi.org/10.1176/appi.ajp.159.4.674
  19. Lee H, Joe KH, Kim W, Park J, Lee DH, Sung KW, et al. Increased leptin and decreased ghrelin level after smoking cessation. Neurosci Lett 2006;409:47-51. https://doi.org/10.1016/j.neulet.2006.09.013
  20. Faerch K, Borch-Johnsen K, Holst JJ, Vaag A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 2009;52:1714-1723. https://doi.org/10.1007/s00125-009-1443-3
  21. Gmitrowicz A, Kucharska A. [Developmental disorders in the fourth edition of the American classification: diagnostic and statistical manual of mental disorders (DSM IV -- optional book)]. Psychiatr Pol 1994;28:509-521.
  22. Donahue RP, Zimmet P, Bean JA, Decourten M, DeCarlo Donahue RA, Collier G, et al. Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study. Ann Epidemiol 1999;9:108- 113. https://doi.org/10.1016/S1047-2797(98)00037-4
  23. Hongu N, Sachan DS. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. J Nutr 2000;130:152-157. https://doi.org/10.1093/jn/130.2.152
  24. Thirthalli J, Benegal V. Psychosis among substance users. Curr Opin Psychiatry 2006;19:239-245. https://doi.org/10.1097/01.yco.0000218593.08313.fd
  25. Aloe L, Tuveri MA, Guerra G, Pinna L, Tirassa P, Micera A, et al. Changes in human plasma nerve growth factor level after chronic alcohol consumption and withdrawal. Alcohol Clin Exp Res 1996; 20:462-465. https://doi.org/10.1111/j.1530-0277.1996.tb01076.x
  26. Yun SJ, Park HJ, Yeom MJ, Hahm DH, Lee HJ, Lee EH. Effect of electroacupuncture on the stress-induced changes in brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 2002;318:85-88. https://doi.org/10.1016/S0304-3940(01)02492-2
  27. Angelucci F, Ricci V, Pomponi M, Conte G, Mathe AA, Attilio Tonali P, et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brainderived neurotrophic factor. J Psychopharmacol 2007;21:820-825. https://doi.org/10.1177/0269881107078491
  28. Pu L, Liu QS, Poo MM. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 2006;9:605-607. https://doi.org/10.1038/nn1687
  29. Yeom M, Shim I, Lee HJ, Hahm DH. Proteomic analysis of nicotine- associated protein expression in the striatum of repeated nicotine- treated rats. Biochem Biophys Res Commun 2005;326:321-328. https://doi.org/10.1016/j.bbrc.2004.11.034
  30. Kastin AJ, Pan W, Maness LM, Banks WA. Peptides crossing the blood-brain barrier: some unusual observations. Brain Res 1999;848: 96-100. https://doi.org/10.1016/S0006-8993(99)01961-7